Rinascibella Group ApS: Financial statements 2025
CVR: 29316082
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Rinascibella Group ApS (CVR 29316082) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -5,149 and a net result of DKK -6,061 compared with DKK 24,225 the year before. Equity in the 2025 report amounted to DKK 10,599. The solvency ratio was 26.2%.
- Gross Profit
- DKK -5,149
- Profit/Loss
- DKK -6,061
- Equity
- DKK 10,599
- Total Assets
- DKK 40,403
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -5 t. | -6 t. | 11 t. | 0 |
| 2024 | - | 25 t. | 24 t. | 17 t. | 0 |
| 2023 | - | -3 t. | -4 t. | -8 t. | 0 |
| 2022 | - | -22 t. | -23 t. | -3 t. | 0 |
| 2021 | 18 t. | -285 t. | -292 t. | 20 t. | - |
Official annual report
How creditworthy is Rinascibella Group ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Rinascibella Group ApS has published its annual report for 2024. Gross profit came to DKK 25,163, and the net result was DKK 24,225.
About Rinascibella Group ApS
Rinascibella Group ApS is a Danish company of the type Anpartsselskab based in Hinnerup, founded in 2006. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named MAKKY INVEST ApS. The management consists of Mehrdad Makky. The company is owned by MAKKY HOLDING ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -5,149 and a net result of DKK -6,061 compared with DKK 24,225 the year before. Equity in the 2025 report amounted to DKK 10,599.